Biological Dynamics announced the publication of data in ACS Nano demonstrating that the company’s proprietary lab-on-a-chip ExoVerita™ system can simplify and streamline the process for isolation and recovery of exosomes. The company is using this technology to develop a portfolio ...
Read More »VWR to Distribute Transgenomic’s ICEme Kits That Enable Liquid Biopsy-Based Cancer Research on Existing Platforms
BUSINESS WIRE –Transgenomic, Inc. (NASDAQ: TBIO) today announced it has signed a non-exclusive agreement with VWR (NASDAQ: VWR) for distribution of its ICEme™ Mutation Enrichment Kits to researchers and laboratories in North America. The kits, which are based on Transgenomic’s ...
Read More »Foundation Medicine Announces Commercial Launch of Liquid Biopsy Assay, FoundationACT™
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Foundation Medicine, Inc. (NASDAQ:FMI) today announced the launch of FoundationACT (Assay for Circulating Tumor DNA), an analytically validated and accurate blood-based circulating tumor DNA (ctDNA) assay that provides patients and oncologists with a new option for comprehensive genomic ...
Read More »